Germany became attractive for First-in-Human trials

News of June 5th, 2024

We interviewed our Medical Director, the clinical pharmacologist responsible for all clinical trials at SocraTec, about first-in-human trials. He explains why Germany has become more attractive again for first-in-human studies.

You can find the interview on LinkedIn here

All fine on single